Benzodiazepines

Rising prescriptions for psychiatric medications are partly a result of longer-term treatment and increasing population, according to an article by Joanna Moncrieff and Stephen...

Jürgen Margraf and Silvia Schneider, both well-known psychologists at the University of Bochum in Germany, claim that psychotropic drugs are no solution to mental...

A review of all the relevant research comparing benzodiazepines (BDZ) to antidepressants (AD) for the treatment of anxiety was published Psychotherapy and Psychosomatics this Friday....

It was the first time in my Klonopin journey it occurred to me the problem might not be inherent in me. The problem might actually be the Klonopin. Convinced my very life was at stake, I made the firm decision to get off the stuff once and for all.

Study details Medicaid-insured birth cohort’s exposure to psychiatric medications and mental health services.

Infants exposed to SSRIs and benzodiazepines during pregnancy show impaired neurologic functioning in the first month after birth, according to a new study published in the American Journal of Psychiatry. While infants exposed SSRIs alone showed neurobehavioral effects throughout the first month, those exposed to an SSRI and a benzodiazepine had more significant problems.

Benzodiazepine medications that are commonly used for calming or sedating people can sometimes apparently cause violent or aggressive responses in some people, according to...

Research from London and Taipei finds that neuroleptic malignant syndrome (NMS) is associated with the number of different antipsychotics used (polypharmacy), rather than the overall...

Note: The episode did not air as expected. ABC indicates it will air Tuesday, January 21. Six weeks ago a producer from ABC World News with Diane Sawyer contacted me. “ABC wants to do a piece on addiction and prescription drugs,” she told me. “Would I agree to an interview?” I was not without reservations. I have a healthy disregard for much of mainstream news, but I also realize their reach and potency. The proposition was risky, but one which I decided to take. It’s a cliché, but one with truth: If one person can benefit, then it’s worth it. I said “yes.”

I began to have transient moments where I would feel oddly disconnected from my environment or wake up and feel like I was coming out of my skin. I did not know it at the time, but I was experiencing interdose benzodiazepine withdrawal and it would end up leading me down a path of polypharmacy.

When I was born, everyone was expecting me to have arms. The doctor's mind raced; how am I going to tell this mother and the father that their son has hands but not arms? If he's missing so much in his extremities, mustn’t he also be missing a mind? My mom looked into my eyes and knew - in a way that only mothers know - that I had a mind, and spirit.

Researchers from the Cochrane Center and University of Copenhagen in Denmark, publishing in the May issue of Addiction, "explore the rationale for claiming that...

In 1980, the British Medical Journal published a “Systematic Review of the Benzodiazepines” by the Committee on the Review of Medicines. The committee denied the addictive potential of Benzodiazepines and limited their suggestions to short term use. The results have been devastating.

Two years ago, when I first felt the dizzy confusion of benzo disability, I talked about it openly. I remember discussing it briefly with an older friend who found my plight strangely fascinating. He asked if I remembered Quaaludes, a sedative-hypnotic that was all the rage in the 1960s and ‘70s. “We called them ‘Stumble Biscuits,’” he told me, “because you’d stumble down the street and hit one car and then stumble over and hit something else and it was just happy and goofy. It’s too bad they took them off the market. Those things were great.”

As the benzodiazepine crisis spreads throughout the United States and other parts of the world, so does the debate within the benzo victim/survivor community. We know that it can be terribly invalidating to label and treat a person as a “drug addict” who is only physically dependent on benzos — and taking these drugs exactly as prescribed by a doctor. However, it can be equally invalidating to deny that “iatrogenic benzo dependence” intersects in multiple ways in the lives of people struggling with “addiction.” People will ALSO SUFFER when yanked off of their benzos, or forced into similar rapid tapers when a doctor becomes aware of their addiction history. 

Three out of four users of the sedative, zolpidem (brand name Ambien), do not follow FDA recommendations to reduce risk.

A recent article in the American Journal of Public Health calls for policy level interventions to reduce the use of benzodiazepines, drugs commonly prescribed...

Dr. Raymond Armstrong and I are currently working together to push Texas lawmakers to adopt restrictions on the prescription of benzodiazepines and sleep drugs. We feel fortunate to be able to draw from the experience of the benzo movement in Massachusetts, and we are grateful for the information that long time advocates like Geraldine Burns have provided us.

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

With drugs for ADHD increasing 17%, and an "unprecedented increase in patients taking antidepressants and antipsychotics," overall prescription drug sales in the United States...

This is the second of a series of excerpts from Cracked Open, a book whose unintentional beginning came after I became physically dependent on Ativan in 2010. After a year of following my doctor’s orders for daily use to treat insomnia, my body and mind began to fall apart. I’m serializing the book here – before sending it out into the world – because MIA became a lighthouse for me. I want this community’s feedback because I want to help make a difference. I want my words and message to be clear and strong.

Despite safety concerns, a new study reveals that there has been no change in the use of benzodiazepines in the elderly from 2001 to 2010.

The Massachusetts Benzo Bill H4062: Informed consent for benzodiazepines and non-benzodiazepine hypnotics was just scheduled to be heard by the Joint Committee on Mental Health and Substance Abuse on Monday, April 4th. Less than a week away! The committee will decide whether the bill moves forward to the house and senate, goes to study, or is denied.

Massachusetts Bill HD 4554 needs to gain sufficient state representative support by Tuesday, March 1, 2016. This bill will put restrictions on the prescribing of benzodiazepines and non-benzodiazepine sleep aids, and will require that all patients be informed of the potential dangers of these drugs, specifically the dangers of long-term use.

Confronting existential anxiety through “Basal Exposure Therapy” shows promising results in people withdrawing from psychotropic drugs.